China has become one of the world’s fastest-growing pharmaceutical and biotechnology markets. With a population exceeding 1.4 billion, rising healthcare investments, and increasing innovation in drug development, the country has become a strategic destination for global pharmaceutical companies. However, entering the Chinese pharmaceutical market requires strict compliance with complex regulatory frameworks and robust pharmacovigilance systems….